IMMR Q3 2025 Earnings EPS Surges Past Estimates Stock Rises on Strong Licensing Performance ALBT Q1 2026 Earnings Narrowing Losses and Strategic Progress Amid No Revenue MTRX Q1 2026 Earnings Strong EPS Beat Signals Operational Momentum OLP Q1 2026 Earnings EPS Surpasses Estimates as Management Highlights Portfolio Performance LMT Q1 2026 Earnings Defense Giant Posts EPS Miss but Shares Edge Higher Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises